ArticleJournal of family medicine and primary care2025
Correlation between risk of malignancy index and histopathological findings in ovarian tumors.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian tumors are one of the most frequent gynecological issues. According to Globocan death projections for 2022, more than 8 million women are predicted to lose their lives to ovarian cancer globally. The risk of malignancy index (RMI) is derived from the product of the ultrasonographic (USG) score (U), menopausal status score (M), and serum CA-125 value. It is an effective technique for diagnosing ovarian malignancy. The aim of the study was to determine the diagnostic accuracy of RMI 3 in ovarian tumors. Materials and Methods: This was a prospective observational study and was carried out in the Obstetrics and Gynecology Department over the course of 1 year. In total, 86 patients were enrolled in the study. Patient underwent all routine investigations, including ultrasound whole abdomen and CA-125. RMI 3 was calculated. All the patients underwent laparotomy. The histopathological report of the ovarian tumors was analyzed for correlation with the RMI score. Results: In our study, maximum number of patients were pre-menopausal (65 (75.6%)) and multiparous (61.6% (53/86)). The RMI score (cutoff at 225 by receiver-operator characteristic curve) had the highest specificity at 90.6% and positive predictive value at 70.0%, while the USG score had the highest sensitivity at 86.4% and negative predictive value at 94.6%. Both the RMI score (cutoff at 225) and the USG score had similar diagnostic accuracy of 83.7%. Conclusion: This study concluded that RMI is an effective technique for diagnosing ovarian tumors with a high probability of malignancy than individual indicators such as CA-125, menopausal score, and ultrasound score. It will help in timely referral of patients to gynecological oncology centers for their optimal surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.